<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC6025560/results/search/drug/results.xml">
  <result pre="approved for treatment of EBV infections. Epstein–Barr virus maribavir antiviral" exact="acyclovir" post="ganciclovir 1. Introduction Why is it that despite the"/>
  <result pre="for treatment of EBV infections. Epstein–Barr virus maribavir antiviral acyclovir" exact="ganciclovir" post="1. Introduction Why is it that despite the profusion"/>
  <result pre="favorable therapeutic index of 850 [3]. The antiviral effect of" exact="acyclovir" post="is the result of ACV-triphosphate’s interaction with the EBV"/>
  <result pre="when used selectively. 2. EBV Latency and Antivirals However, neither" exact="acyclovir" post="nor other drugs have any effect on latent infection,"/>
  <result pre="might be beneficial. However, in a multicenter, double-blind, placebo-controlled trial," exact="prednisolone" post="administered with ACV for treatment of IM inhibited oropharyngeal"/>
  <result pre="historic group PTLD developed in 4.2% of the patients. 5." exact="Ganciclovir" post="and Valgancyclovir The effects of ganciclovir (GCV) and valgancyclovir"/>
  <result pre="of the patients. 5. Ganciclovir and Valgancyclovir The effects of" exact="ganciclovir" post="(GCV) and valgancyclovir (VGCV) prophylaxis on EBV load was"/>
  <result pre="has a longer intracellular half-life than ACV-TP. 7. Valomaciclovir The" exact="L-valine" post="ester of H2G, (i.e., MIV-606, (valomaciclovir, VALM)) is a"/>
  <result pre="viral targets, MBV may also affect downstream targets indirectly. 9." exact="Cidofovir" post="Finally, there is some basis for using an antiviral"/>
  <result pre="some basis for using an antiviral drug in tumorous tissue." exact="Cidofovir" post="(HPMPC), a nucleoside analogue, has been used for treatment"/>
  <result pre="xenografts in nude mice, injection into the tumor tissue with" exact="cidofovir" post="suppressed growth of the NPC tissue [30,31]. The ribonucleotide"/>
  <result pre="of the NPC tissue [30,31]. The ribonucleotide reductase (RR) inhibitors" exact="hydroxyurea" post="and didox (3,4-dihydroxybenzohydroxamic acid) enhanced cidofovir-induced apoptosis in EBV-transformed"/>
  <result pre="authors declare no conflict of interest. References References 1.TynellE.AureliusE.BrandellA.JulanderI.WoodM.YaoQ.Y.RickinsonA.AkerlundB.AnderssonJ.Acyclovir and" exact="prednisolone" post="treatment of acute infectious mononucleosis: A multicenter, double-blind, placebo-controlled"/>
  <result pre="multicenter, double-blind, placebo-controlled studyJ. Infect. Dis.199617432433110.1093/infdis/174.2.3248699062 2.PaganoJ.S.DattaA.K.Perspectives on interactions of" exact="acyclovir" post="with Epstein-Barr and other herpes virusesAm. J. Med.198273182610.1016/0002-9343(82)90057-26285710 3.PaganoJ.S.SixbeyJ.W.LinJ.C.Acyclovir"/>
  <result pre="3.PaganoJ.S.SixbeyJ.W.LinJ.C.Acyclovir and Epstein-Barr virus infectionJ. Antimicrob. Chemother.198312Suppl. B11312110.1093/jac/12.suppl_B.1136313591 4.ColbyB.M.ShawJ.E.ElionG.B.PaganoJ.S.Effect of" exact="acyclovir" post="[9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replicationJ. Virol.1980345605686246281 5.AdamsA.LindahlT.Epstein-Barr virus"/>
  <result pre="Transplant.20022154755410.1016/S1053-2498(01)00407-711983544 13.HierroL.Diez-DoradoR.DiazC.De la VegaA.FraucaE.CamarenaC.Munoz-BartoloG.Gonzalez de ZarateA.Lopez SantamariaM.JaraP.Efficacy and safety of" exact="valganciclovir" post="in liver-transplanted children infected with Epstein-Barr virusLiver Transpl.2008141185119310.1002/lt.2149818668670 14.GreenM.MichaelsM.G.Epstein-Barr"/>
  <result pre="deep sequencingAntimicrob. Agents Chemother.2014584697470210.1128/AAC.03214-1424890586 23.ChouS.BowlinT.L.Cytomegalovirus UL97 mutations affecting cyclopropavir and" exact="ganciclovir" post="susceptibilityAntimicrob. Agents Chemother.20115538238410.1128/AAC.01259-1021041510 24.LurainN.S.ChouS.Antiviral drug resistance of human cytomegalovirusClin."/>
  <result pre="cytomegalovirusClin. Microbiol. Rev.20102368971210.1128/CMR.00009-1020930070 25.ChouS.Cytomegalovirus UL97 mutations in the era of" exact="ganciclovir" post="and maribavirRev. Med. Virol.20081823324610.1002/rmv.57418383425 26.WangF.Z.RoyD.GershburgE.WhitehurstC.B.DittmerD.P.PaganoJ.S.Maribavir inhibits epstein-barr virus transcription"/>
 </snippets>
</snippetsTree>
